AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOGEN INC. Director's Dealing 2024

Jan 31, 2024

30291_dirs_2024-01-31_ad23d605-b302-452d-aac1-ec357eab5b9f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOGEN INC. (BIIB)
CIK: 0000875045
Period of Report: 2024-01-29

Reporting Person: Izzar Rachid (Head of Global Product Strat.)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-01-29	Performance Stock Unit	$0	A	1370	Acquired	2024-02-18	Common Stock (1370)	Direct

Footnotes

F1: Represents shares earned upon satisfaction of certain performance conditions associated with performance stock units granted on February 18, 2021. The PSUs will vest on February 18, 2024.